Zacks: Analysts Expect Israel Chemicals Ltd (NYSE:ICL) to Post $0.11 Earnings Per Share

Analysts expect that Israel Chemicals Ltd (NYSE:ICL) will post $0.11 earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have provided estimates for Israel Chemicals’ earnings, with the highest EPS estimate coming in at $0.11 and the lowest estimate coming in at $0.10. Israel Chemicals posted earnings of $0.10 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 10%. The business is expected to issue its next quarterly earnings results on Thursday, November 7th.

On average, analysts expect that Israel Chemicals will report full-year earnings of $0.42 per share for the current fiscal year, with EPS estimates ranging from $0.40 to $0.45. For the next fiscal year, analysts forecast that the business will report earnings of $0.47 per share, with EPS estimates ranging from $0.45 to $0.50. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow Israel Chemicals.

Israel Chemicals (NYSE:ICL) last posted its earnings results on Wednesday, July 31st. The basic materials company reported $0.12 EPS for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.01. Israel Chemicals had a return on equity of 14.03% and a net margin of 9.04%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same quarter last year, the company earned $0.09 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year.

Several analysts recently commented on the company. Zacks Investment Research raised Israel Chemicals from a “hold” rating to a “strong-buy” rating and set a $6.00 price objective for the company in a report on Friday, June 7th. ValuEngine lowered Israel Chemicals from a “buy” rating to a “hold” rating in a report on Saturday, June 1st. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $5.94.

Institutional investors and hedge funds have recently modified their holdings of the stock. Bank of America Corp DE lifted its position in Israel Chemicals by 190.7% during the fourth quarter. Bank of America Corp DE now owns 539,969 shares of the basic materials company’s stock valued at $3,057,000 after purchasing an additional 354,192 shares in the last quarter. Eagle Global Advisors LLC lifted its position in Israel Chemicals by 6.9% during the first quarter. Eagle Global Advisors LLC now owns 327,000 shares of the basic materials company’s stock valued at $1,713,000 after purchasing an additional 21,000 shares in the last quarter. BlackRock Inc. lifted its position in shares of Israel Chemicals by 5.6% in the fourth quarter. BlackRock Inc. now owns 287,546 shares of the basic materials company’s stock valued at $1,628,000 after acquiring an additional 15,307 shares in the last quarter. Ballentine Partners LLC lifted its position in shares of Israel Chemicals by 20.5% in the second quarter. Ballentine Partners LLC now owns 26,747 shares of the basic materials company’s stock valued at $139,000 after acquiring an additional 4,546 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Israel Chemicals by 62.4% in the first quarter. Quadrant Capital Group LLC now owns 25,143 shares of the basic materials company’s stock valued at $130,000 after acquiring an additional 9,664 shares in the last quarter. 7.73% of the stock is owned by institutional investors.

Shares of ICL remained flat at $$4.85 during trading hours on Monday. The company had a trading volume of 142,500 shares, compared to its average volume of 164,666. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 0.85. Israel Chemicals has a one year low of $4.72 and a one year high of $6.90. The company has a market cap of $6.23 billion, a price-to-earnings ratio of 13.11, a PEG ratio of 1.19 and a beta of 0.83. The firm has a 50 day moving average price of $5.20 and a two-hundred day moving average price of $5.33.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Featured Article: Differences Between Momentum Investing and Long Term Investing

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.